首页> PloS one> The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension.

The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension.

导出 OA

翻译打印收藏纠错

第一作者： Mingfei,Li

第一单位： Center for Healthcare Organization and Implementation Research (CHOIR), Bedford VA Healthcare System, Bedford, Massachusetts, United States of America.;Department of Mathematical Sciences, Bentley University, Waltham, Massachusetts, United States of America.

作者： Mingfei,Li ^[1] ; Ying,Wang ^[2] ; Ndindam,Ndiwane ^[3] ; Michelle B,Orner ^[3] ; Natalia,Palacios ^[4] ; Brant,Mittler ^[5] ; Dan,Berlowitz ^[6] ; Lewis E,Kazis ^[7] ; Weiming,Xia ^[8]

作者单位： Center for Healthcare Organization and Implementation Research (CHOIR), Bedford VA Healthcare System, Bedford, Massachusetts, United States of America.;Department of Mathematical Sciences, Bentley University, Waltham, Massachusetts, United States of America. ^[1] Department of Mathematical Sciences, Bentley University, Waltham, Massachusetts, United States of America. ^[2] Center for Healthcare Organization and Implementation Research (CHOIR), Bedford VA Healthcare System, Bedford, Massachusetts, United States of America. ^[3] Department of Public Health, Zuckerberg College of Health Sciences, University of Massachusetts Lowell, Lowell, Massachusetts, United States of America.;Geriatric Research Education Clinical Center, Bedford VA Healthcare System, Bedford, Massachusetts, United States of America. ^[4] Department of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America. ^[5] Department of Public Health, Zuckerberg College of Health Sciences, University of Massachusetts Lowell, Lowell, Massachusetts, United States of America. ^[6] Center for Healthcare Organization and Implementation Research (CHOIR), Bedford VA Healthcare System, Bedford, Massachusetts, United States of America.;Department of Health Law, Policy and Management, Boston University School of Public Health, Boston, Massachusetts, United States of America. ^[7] Geriatric Research Education Clinical Center, Bedford VA Healthcare System, Bedford, Massachusetts, United States of America.;Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts, United States of America. ^[8]